SDC1 and cancer: Hepatocarcinogenesis was followed up in transgenic and wild-type animals, and a six month delay in the formation of overt cancer was observed in hSDC1+/+ mice, confirming the assumption that SDC1 suppresses oncogenesis in the liver.